We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Omnicom Group
OMC
$21.6B
| $20.5M | 0.05% |
+253,500
| New | +$19.9M |
|
377
Cognizant
CTSH
$24.9B
| $20.5M | 0.05% |
329,900
+4,700
| +1% | +$290K |
|
378
Equitable Holdings
EQH
$13B
| $20.4M | 0.05% |
+825,000
| New | +$19.1M |
|
|
HI
379
DELISTED
Hillenbrand
HI
| $20.4M | 0.05% |
+613,053
| New | +$19.4M |
|
380
Amcor
AMCR
$20.8B
| $20.2M | 0.05% |
373,438
-17,920
| -5% | -$898K |
|
381
Hyliion Holdings
HYLN
$635M
| $20.2M | 0.05% |
2,025,000
| – | – |
|
382
MGM Resorts International
MGM
$11.4B
| $20.1M | 0.05% |
605,000
-28,500
| -4% | -$868K |
|
|
AMK
383
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $20.1M | 0.05% |
693,290
+176,248
| +34% | +$4.61M |
|
|
SEI
384
Solaris Energy Infrastructure
SEI
$3.15B
| $20.1M | 0.05% |
1,435,367
| – | – |
|
385
Teleflex
TFX
$6.05B
| $20M | 0.05% |
53,055
-3,200
| -6% | -$1.1M |
|
|
K
386
DELISTED
Kellanova
K
| $19.9M | 0.05% |
307,185
-14,697
| -5% | -$890K |
|
387
Halozyme
HALO
$9.79B
| $19.9M | 0.05% |
1,125,000
+375,000
| +50% | +$6.49M |
|
388
AstraZeneca
AZN
$263B
| $19.9M | 0.05% |
200,000
-50,000
| -20% | -$4.71M |
|
389
Ameriprise Financial
AMP
$48.3B
| $19.9M | 0.05% |
119,268
-47,000
| -28% | -$7.28M |
|
390
Nucor
NUE
$58.6B
| $19.8M | 0.05% |
351,835
-9,524
| -3% | -$519K |
|
|
AUY
391
DELISTED
Yamana Gold, Inc.
AUY
| $19.7M | 0.05% |
4,990,200
-3,200,000
| -39% | -$11.2M |
|
392
Church & Dwight Co
CHD
$23.4B
| $19.7M | 0.05% |
279,374
-13,600
| -5% | -$966K |
|
393
Healthpeak Properties
DOC
$15.1B
| $19.6M | 0.05% |
569,343
-27,400
| -5% | -$959K |
|
394
Verisk Analytics
VRSK
$25.4B
| $19.4M | 0.05% |
129,600
-69,100
| -35% | -$10.2M |
|
|
WCG
395
DELISTED
Wellcare Health Plans, Inc.
WCG
| $19.2M | 0.05% |
58,000
-2,800
| -5% | -$841K |
|
396
Oneok
OKE
$57.2B
| $19.1M | 0.05% |
+252,100
| New | +$18M |
|
397
Lincoln National
LNC
$8.73B
| $19M | 0.05% |
321,461
+219,000
| +214% | +$12.9M |
|
398
Conagra Brands
CAG
$6.94B
| $18.9M | 0.05% |
552,945
-26,900
| -5% | -$779K |
|
399
Flowserve
FLS
$9.71B
| $18.9M | 0.05% |
378,769
+189,816
| +100% | +$9.09M |
|
400
Envista
NVST
$4.44B
| $18.7M | 0.05% |
630,814
+180,814
| +40% | +$5.14M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.